Humacyte, Inc. (NASDAQ:HUMA) Q3 2023 Earnings Call Transcript

Unidentified Analyst: Great. Thanks a lot.

Operator: Our next question comes from Bruce Jackson from The Benchmark Company. Your line is open.

Bruce Jackson: Hi, congratulations on all of the progress. Most of my questions have been answered. I just — you got the VEITH Symposium coming up here shortly. Are there any particular presentations that you’re excited about?

Laura Niklason: I’m excited about Humacyte’s presentations. But I’m also excited about a couple of other things that we haven’t mentioned. I will say that there’s a surgeon from the Mayo Clinic, who’s been doing peripheral artery disease work that he’s doing an investigator-sponsored study with the HAV in patients with critical limb ischemia who are facing potential amputation. So, he’s going to talk about those results, which are very encouraging. We also have a joint presentation with Fresenius, where we’re presenting some early results of a data dive that we’re doing to look into the types of patients who have problems with their access, either access failures or frequent access infections to really hone in on which dialysis patients may benefit from the HAV in the long term.

Bruce Jackson: All right. That’s it for me. Thank you.

Operator: I’m seeing no further questions. I’ll turn the call back over to our host.

Laura Niklason: Well, thank you very much for everyone for your time and attention. It’s been an exciting quarter. And everybody at Humacyte is working hard to continue to meet our milestones. As I’ve said, since we went public, we have been delivering on what we said we would deliver on the timelines on which we said we would deliver it, and we’re just continuing to do that. And I’m just so proud of our team and all the hard work that they’ve done, and also all of our collaborators, whether it’s collaborating surgeons or our corporate partners. So, I just want to give a big shout out to everybody who’s helped us get this far.

Operator: That concludes today’s conference call. Thank you for joining, and have a pleasant day.